Healthcare Resource Utilisation and Costs of Mepolizumab Initiation: A 5-Year National Cohort Analysis. [PDF]
Bourdin A+7 more
europepmc +1 more source
Study protocol for a randomized double-blinded placebo-controlled trial on mepolizumab for patients with chronic rhinosinusitis with nasal polyps, NSAID exacerbated respiratory disease and asthma. [PDF]
Lyly A+14 more
europepmc +1 more source
Pituitary dysfunction with eosinophilic granulomatosis with polyangiitis presenting with diabetes insipidus: a case report and review of the literature. [PDF]
Zhang A+6 more
europepmc +1 more source
Real-World Evidence of Administration of Biologic Agents in Patients with Severe Asthma: An Analysis of the Respiratory Department of University Hospital of Patras Asthma Registry. [PDF]
Papaioannou O+11 more
europepmc +1 more source
Dual biological treatments in immune-mediated disorders: a single center experience. [PDF]
Shamriz O+8 more
europepmc +1 more source
Utility of the Basophil Reactivity Test in the Clinical Management of People with Severe Uncontrolled Asthma. [PDF]
García Ródenas MDM+6 more
europepmc +1 more source
Evaluation of Long-Term Response to Biological Therapy in Severe Asthma and Considerations for Treatment Adjustment. [PDF]
Giordani J, Pini A, Pini L.
europepmc +1 more source
Efficacy and Safety of Biologics Targeting Type 2 Inflammation in COPD: A Systematic Review and Network Meta-Analysis. [PDF]
Li S, Yi B, Wang H, Xu X, Yu L.
europepmc +1 more source
Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma. [PDF]
Mobayed H+5 more
europepmc +1 more source